anidulafungin has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, U; Alam, A; Chakraborty, A; Ehtesham, NZ; Hasnain, SE; Kundu, B; Quadir, N; Singh, J; Sundar, D; Vashishtha, S | 1 |
1 other study(ies) available for anidulafungin and Extensively Drug-Resistant Tuberculosis
| Article | Year |
|---|---|
Polypharmacological repurposing approach identifies approved drugs as potential inhibitors of Mycobacterium tuberculosis.
Topics: Anidulafungin; Antitubercular Agents; Bacterial Proteins; Drug Repositioning; Extensively Drug-Resistant Tuberculosis; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary | 2023 |